Ko M.-J.CHIA-YU CHU2019-12-042019-12-0420030007-0963https://www.scopus.com/inward/record.uri?eid=2-s2.0-0348012913&doi=10.1111%2fj.1365-2133.2003.05611.x&partnerID=40&md5=4dfc7455c91026627ffa865c32bf448bhttps://scholars.lib.ntu.edu.tw/handle/123456789/435002[SDGs]SDG3antihistaminic agent; buclizine; doxepin; ethambutol; immunoglobulin G antibody; isoniazid; pyrazinamide; rifampicin; tacrolimus; tuberculostatic agent; aged; blister; case report; clinical feature; drug effect; drug efficacy; drug response; drug use; histology; human; immunofluorescence; letter; lung tuberculosis; male; pemphigoid; priority journal; pruritus; skin biopsy; symptom; Aged; Aged, 80 and over; Hand Dermatoses; Humans; Immunosuppressive Agents; Male; Pemphigoid, Bullous; TacrolimusTopical tacrolimus therapy for localized bullous pemphigoid [3]letter10.1111/j.1365-2133.2003.05611.x146328242-s2.0-0348012913